$3.15
0.258.62%
At close: -
$3.15
0.000500.02%
After Hours: Jun 6, 7:54 PM EDT
Comments
Loading...
ImmunityBio Earnings Estimates, EPS & Revenue | NASDAQ:IBRX | Benzinga
ImmunityBio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS
$-0.150
Quarterly Revenue
$16.52M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$31.22M
Analyze the earnings history of ImmunityBio using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio | -$0.20 | — | — | — | $1.05M | — | — | — | 08/11/2025 | Get Alert |
| IBRX | ImmunityBio | -$0.20 | -$0.14 | -$0.15 | -7.14% | $40.00K | $17.50M | $16.52M | -5.62% | 05/12/2025 | Get Alert |
| IBRX | ImmunityBio | -$0.38 | -$0.26 | -$0.09 | 65.38% | $139.00K | $8.74M | $7.55M | -13.59% | 03/03/2025 | Get Alert |
| IBRX | ImmunityBio | -$0.19 | -$0.17 | -$0.14 | 17.65% | $82.00K | $4.36M | $6.11M | 40.05% | 11/12/2024 | Get Alert |
| IBRX | ImmunityBio | -$0.32 | -$0.17 | -$0.20 | -17.65% | $41.00K | $2.52M | $1.05M | -58.45% | 08/12/2024 | Get Alert |
| IBRX | ImmunityBio | -$0.27 | -$0.16 | -$0.20 | -25.00% | $360.00K | $20.00K | $40.00K | 100.00% | 05/09/2024 | Get Alert |
| IBRX | ImmunityBio | -$0.27 | -$0.18 | -$0.38 | -111.11% | $73.00K | $20.00K | $139.00K | 595.00% | 03/19/2024 | Get Alert |
| IBRX | ImmunityBio | -$0.28 | -$0.27 | -$0.19 | 29.63% | $118.00K | $30.00K | $82.00K | 173.33% | 11/09/2023 | Get Alert |
| IBRX | ImmunityBio | -$0.24 | -$0.23 | -$0.32 | -39.13% | $35.00K | — | $41.00K | — | 08/08/2023 | Get Alert |
| IBRX | ImmunityBio | -$0.26 | $0.00 | -$0.27 | -100.00% | $14.00K | $360.00K | $360.00K | 0.00% | 05/11/2023 | Get Alert |
| IBRX | ImmunityBio | -$0.23 | -$0.22 | -$0.27 | -22.73% | $390.00K | $30.00K | $73.00K | 143.33% | 03/01/2023 | Get Alert |
| IBRX | ImmunityBio | -$0.22 | — | -$0.22 | — | $66.00K | — | $118.00K | — | 11/09/2022 | Get Alert |
| IBRX | ImmunityBio | -$0.23 | — | -$0.24 | — | $339.00K | — | $35.00K | — | 08/08/2022 | Get Alert |
| IBRX | ImmunityBio | -$0.21 | — | -$0.26 | — | $139.00K | — | $14.00K | — | 05/10/2022 | Get Alert |
| IBRX | ImmunityBio | -$0.18 | — | -$0.23 | — | -$147.00K | — | $390.00K | — | 03/02/2022 | Get Alert |
| IBRX | ImmunityBio | -$0.17 | — | -$0.22 | — | $151.00K | — | $66.00K | — | 11/12/2021 | Get Alert |
| IBRX | ImmunityBio | — | — | -$0.23 | — | — | — | $339.00K | — | 08/12/2021 | Get Alert |
| IBRX | ImmunityBio | — | — | -$0.21 | — | — | — | $139.00K | — | 05/14/2021 | Get Alert |
| IBRX | ImmunityBio | — | — | -$0.89 | — | — | — | $111.00K | — | 03/04/2021 | Get Alert |
ImmunityBio (IBRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $-0.15 | $-0.14 | -7.14 % |
| Q4 | 2025-03-03 | $-0.09 | $-0.26 | 65.4 % |
| Q3 | 2024-11-12 | $-0.14 | $-0.17 | 17.6 % |
| Q2 | 2024-08-12 | $-0.20 | $-0.17 | -17.6 % |
ImmunityBio (IBRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-12 | $16.52M | $17.50M | -5.62 % |
| Q4 | 2025-03-03 | $7.55M | $8.74M | -13.6 % |
| Q3 | 2024-11-12 | $6.11M | $4.36M | 40.1 % |
| Q2 | 2024-08-12 | $1.05M | $2.52M | -58.5 % |
FAQ
When is ImmunityBio (NASDAQ:IBRX) reporting earnings?
ImmunityBio (IBRX) is scheduled to report earnings on August 11, 2025. The last reported earnings were for reported on May 12, 2025 for Q1.
What were the latest earnings per share (EPS) for ImmunityBio (NASDAQ:IBRX)?
The Actual EPS was $-0.15, which missed the estimate of $-0.14.
What were ImmunityBio’s (NASDAQ:IBRX) revenues?
The Actual Revenue was $16.5M, which missed the estimate of $17.5M.
Browse earnings estimates, EPS, and revenue on all stocks.
